RUBIN EYAL (Sr. VP & CFO) received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/24/2024ACC: 0001415889-24-023907
Officer· Sr. VP & CFO
Since Sep 2019
+99.01K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
99.01K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+99.01K
Price / share
—
Trade value
—
% of position
17.4%
9/23/2024
570K→669.01K
Total
Net shares
+99.01K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/23/2024 | A · Award | +99.01K | — | — | 17.4% | 570K | 669.01K |
| Total | +99.01K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported